Cargando…

Clinicopathological and prognostic value of long non-coding RNA CCAT1 expression in patients with digestive system cancer

Colon cancer associated transcript-1 (CCAT1) is known to play an important role in numerous types of human cancer, including bladder, prostate and ovarian cancer. However, a consistent perspective has not been established in digestive system cancer (DSC). To explore the prognostic value of CCAT1 in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yue, Xu, Zhihua, Ni, Hao, Jin, Mengxian, Dai, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843303/ https://www.ncbi.nlm.nih.gov/pubmed/36688111 http://dx.doi.org/10.3892/ol.2023.13659

Ejemplares similares

Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis
por: Shi, Deyao, et al.
Publicado: (2017)

Correction: Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis
por: Shi, Deyao, et al.
Publicado: (2017)

Expression of Concern: Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis
Publicado: (2023)

CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma
por: Cai, Yi, et al.
Publicado: (2018)

CCAT 1- A Pivotal Oncogenic Long Non-Coding RNA in Colorectal Cancer
por: Liau, Xiew Leng, et al.
Publicado: (2023)

Roles of Long Non-Coding RNA CCAT2 in Cervical Cancer Cell Growth and Apoptosis
por: Wu, Le, et al.
Publicado: (2016)

Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells
por: Guo, Hua, et al.
Publicado: (2016)

Long non-coding RNA CCAT1 as a diagnostic and prognostic molecular marker in various cancers: a meta-analysis
por: Zhang, Zhihui, et al.
Publicado: (2018)

VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer
por: Barros-Silva, Daniela, et al.
Publicado: (2020)

CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations
por: Redis, Roxana S, et al.
Publicado: (2013)

Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma
por: Fu, Changbo, et al.
Publicado: (2019)

The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis
por: Huang, Shuying, et al.
Publicado: (2016)

Long Non-Coding RNA CCAT2 Activates RAB14 and Acts as an Oncogene in Colorectal Cancer
por: Wang, Dalu, et al.
Publicado: (2021)

Long Non-coding RNA CCAT1 Acts as an Oncogene and Promotes Sunitinib Resistance in Renal Cell Carcinoma
por: Shan, Liping, et al.
Publicado: (2020)

Vitamin D Suppresses Ovarian Cancer Growth and Invasion by Targeting Long Non-Coding RNA CCAT2
por: Wang, Liye, et al.
Publicado: (2020)

Enhancer-derived long non-coding RNAs CCAT1 and CCAT2 at rs6983267 has limited predictability for early stage colorectal carcinoma metastasis
por: Thean, Lai Fun, et al.
Publicado: (2021)

Long non-coding RNAs CCAT1 and CCAT2 in colorectal liver metastases are tumor-suppressive via MYC interaction and might predict patient outcomes
por: Franz, Clemens, et al.
Publicado: (2023)

Study the relationship between long non-coding RNA (CCAT1) expression and CDK4 expression levels in Egyptian patients with preeclampsia
por: Abd El Gayed, Eman Masoud, et al.
Publicado: (2022)

Long non-coding RNA CCAT1 modulates neuropathic pain progression through sponging miR-155
por: Dou, Lidong, et al.
Publicado: (2017)

Long non-coding RNA CCAT2 functions as an oncogene in hepatocellular carcinoma, regulating cellular proliferation, migration and apoptosis
por: ZHOU, NING, et al.
Publicado: (2016)

Corrigendum: Long non-coding RNA CCAT1 acts as an oncogene and promotes sunitinib resistance in renal cell carcinoma
por: Shan, Liping, et al.
Publicado: (2023)

Clinicopathological value of long non-coding RNA profiles in gastrointestinal stromal tumor
por: Zhao, Yan, et al.
Publicado: (2021)

Clinicopathological association and prognostic value of long non-coding RNA CASC9 in patients with cancer: A meta-analysis
por: Duan, Hou-Yu, et al.
Publicado: (2020)

Long non-coding RNA CCAT2 promotes prostate cancer cell proliferation and invasion by regulating the Wnt/β-catenin signaling pathway
por: He, Peng, et al.
Publicado: (2020)

Knockdown of long non-coding RNA CCAT2 suppresses the progression of thyroid cancer by inhibiting the Wnt/β-catenin pathway
por: Xin, Suping, et al.
Publicado: (2020)

Long non-coding RNA CCAT1 enhances human non-small cell lung cancer growth through downregulation of microRNA-218
por: Zhao, Lijiang, et al.
Publicado: (2020)

CCAT: Combinatorial Code Analysis Tool for transcriptional regulation
por: Jiang, Peng, et al.
Publicado: (2014)

Prognostic and clinicopathological role of long non-coding RNA UCA1 in various carcinomas
por: Wang, Xiaoxiong, et al.
Publicado: (2017)

Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression
por: Shang, Anquan, et al.
Publicado: (2020)

Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p
por: Ma, M-Z, et al.
Publicado: (2015)

Long Non-Coding RNA CCAT1 Acts as a Competing Endogenous RNA to Regulate Cell Growth and Differentiation in Acute Myeloid Leukemia
por: Chen, Lianxiang, et al.
Publicado: (2016)

shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells
por: Li, Jianfa, et al.
Publicado: (2016)

Long non‐coding RNA CCAT1 sponges miR‐490 to enhance cell proliferation and migration of non‐small cell lung cancer
por: Wang, Jingluan, et al.
Publicado: (2020)

Glioma cells enhance angiogenesis and inhibit endothelial cell apoptosis through the release of exosomes that contain long non-coding RNA CCAT2
por: Lang, Hai-Li, et al.
Publicado: (2017)

Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving
por: Wang, De-Ying, et al.
Publicado: (2020)

Prognostic and Clinicopathological Significance of Long Non-coding RNA PANDAR Expression in Cancer Patients: A Meta-Analysis
por: Han, Lizhi, et al.
Publicado: (2019)

Prognostic Value of Long Non-Coding RNA HOTAIR in Various Cancers
por: Deng, Qiwen, et al.
Publicado: (2014)

Prognostic value of long non-coding RNA signatures in bladder cancer
por: He, Anbang, et al.
Publicado: (2019)

Prognostic Value of Macrophage-Associated Long Non-Coding RNA Expression for Hepatocellular Carcinoma
por: Chen, Guan-Yu, et al.
Publicado: (2022)

The Roles of the Colon Cancer Associated Transcript 2 (CCAT2) Long Non-Coding RNA in Cancer: A Comprehensive Characterization of the Tumorigenic and Molecular Functions
por: Pirlog, Radu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_e20ca00po7r50tik47b22jrmrn